Literature DB >> 28134973

Fucosterol, isolated from Ecklonia stolonifera, inhibits adipogenesis through modulation of FoxO1 pathway in 3T3-L1 adipocytes.

Ji-Hyun Lee1, Hyun Ah Jung2, Min Jae Kang1, Jae Sue Choi3, Gun-Do Kim1.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the effects of fucosterol on adipogenesis of 3T3-L1 preadipocytes and its underlying mechanisms.
METHODS: Fucosterol, isolated from brown algae, Ecklonia stolonifera. We investigated the levels of lipid accumulation using Oil Red O staining. We conducted Western blot analysis to investigate regulatory effects of fucosterol on expression of phosphoinositide 3-kinase (PI3K), Akt, extracellular signal-regulated kinase (ERK), forkhead box protein O 1 (FoxO1) in 3T3-L1 adipocytes. KEY
FINDINGS: Fucosterol significantly reduced intracellular lipid accumulation of 3T3-L1 adipocytes at concentrations of 25 and 50 μm. Fucosterol downregulated insulin-triggered PI3K/Akt, and ERK pathways. It subsequently decreased expression of adipogenic transcription factors, including PPARγ, C/EBPα and SREBP-1. In addition, fucosterol enhanced SirT1 expression while decreased phospho-FoxO1 expression which resulted in the activation of FoxO1.
CONCLUSIONS: We revealed that fucosterol inhibited adipogenesis of 3T3-L1 preadipocytes through modulation of FoxO signalling pathway. Therefore, our results suggest that fucosterol may be used for novel agents for the treatment of obesity.
© 2017 Royal Pharmaceutical Society.

Entities:  

Keywords:  zzm321990Ecklonia stoloniferazzm321990; 3T3-L1 adipocytes; FoxO1; adipogenesis; fucosterol

Mesh:

Substances:

Year:  2017        PMID: 28134973     DOI: 10.1111/jphp.12684

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

1.  Fucosterol Protects against Concanavalin A-Induced Acute Liver Injury: Focus on P38 MAPK/NF-κB Pathway Activity.

Authors:  Wenhui Mo; Chengfen Wang; Jingjing Li; Kan Chen; Yujing Xia; Sainan Li; Ling Xu; Xiya Lu; Wenwen Wang; Chuanyong Guo
Journal:  Gastroenterol Res Pract       Date:  2018-07-17       Impact factor: 2.260

2.  Deciphering Molecular Mechanism of the Neuropharmacological Action of Fucosterol through Integrated System Pharmacology and In Silico Analysis.

Authors:  Md Abdul Hannan; Raju Dash; Abdullah Al Mamun Sohag; Il Soo Moon
Journal:  Mar Drugs       Date:  2019-11-13       Impact factor: 5.118

Review 3.  Recent advances in pharmacological research on Ecklonia species: a review.

Authors:  Prashamsa Koirala; Hyun Ah Jung; Jae Sue Choi
Journal:  Arch Pharm Res       Date:  2017-08-24       Impact factor: 4.946

Review 4.  Phytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders.

Authors:  Teresa Vezza; Francisco Canet; Aranzazu M de Marañón; Celia Bañuls; Milagros Rocha; Víctor Manuel Víctor
Journal:  Antioxidants (Basel)       Date:  2020-12-12

5.  Gold Nanoparticles Using Ecklonia stolonifera Protect Human Dermal Fibroblasts from UVA-Induced Senescence through Inhibiting MMP-1 and MMP-3.

Authors:  Eun-Sook Jun; Yeong Jin Kim; Hyung-Hoi Kim; Sun Young Park
Journal:  Mar Drugs       Date:  2020-08-19       Impact factor: 5.118

Review 6.  Fucosterol of Marine Macroalgae: Bioactivity, Safety and Toxicity on Organism.

Authors:  Maria Dyah Nur Meinita; Dicky Harwanto; Gabriel Tirtawijaya; Bertoka Fajar Surya Perwira Negara; Jae-Hak Sohn; Jin-Soo Kim; Jae-Suk Choi
Journal:  Mar Drugs       Date:  2021-09-27       Impact factor: 5.118

7.  Cistanche promotes the adipogenesis of 3T3-L1 preadipocytes.

Authors:  Ping Zhang; Le Su; Xiuyu Ji; Feifan Ma; Qiulin Yue; Chen Zhao; Song Zhang; Xin Sun; Kunlun Li; Lin Zhao
Journal:  PLoS One       Date:  2022-03-01       Impact factor: 3.240

Review 8.  Overview on the Antihypertensive and Anti-Obesity Effects of Secondary Metabolites from Seaweeds.

Authors:  Ana M L Seca; Diana C G A Pinto
Journal:  Mar Drugs       Date:  2018-07-14       Impact factor: 5.118

Review 9.  Potential Anti-Aging Substances Derived from Seaweeds.

Authors:  Lei Cao; Sang Gil Lee; Kwon Taek Lim; Hyeung-Rak Kim
Journal:  Mar Drugs       Date:  2020-11-18       Impact factor: 5.118

Review 10.  Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases.

Authors:  Daniela Gabbia; Sara De Martin
Journal:  Molecules       Date:  2020-09-12       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.